Filing Details

Accession Number:
0001209191-14-071984
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-01 17:18:44
Reporting Period:
2014-11-28
Filing Date:
2014-12-01
Accepted Time:
2014-12-01 17:18:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596946 Quotient Ltd QTNT In Vitro & In Vivo Diagnostic Substances (2835) 264719797
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1409103 Galen Partners V Lp 680 Washington Blvd.
Stamford CT 06901
No No Yes No
1409104 Galen Partners International V Lp 680 Washington Blvd.
Stamford CT 06901
No No Yes No
1421162 Galen Management, Llc 680 Washington Blvd.
Stamford CT 06901
No No Yes No
1605684 Galen Partners V, L.l.c. 680 Washington Blvd.
Stamford CT 06901
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-11-28 157,895 $9.50 5,837,397 No 4 P Indirect See FN
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See FN
Footnotes
  1. The ordinary shares were acquired in connection with the issuer's private placement. Galen Partners V LP ("Galen V") acquired 145,473 ordinary shares and Galen Partners International V LP ("Galen International V") acquired 12,422 ordinary shares.
  2. Includes 5,239,293 ordinary shares held of record by Galen V, 447,400 ordinary shares held of record by Galen International V and 150,704 ordinary shares held of record by Galen Management, LLC. Galen Parnters V, L.L.C. serves as the sole General Partner of Galen V and Galen International V and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.